Cited by 4,051Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., St George-Hyslop, P. H.·1995·Nature

DOI 10.1038/375754a0

Open this paper in CoChat — free account

Abstract

Some cases of Alzheimer's disease are inherited as an autosomal dominant trait. Genetic linkage studies have mapped a locus (AD3) associated with susceptibility to a very aggressive form of Alzheimer's disease to chromosome 14q24.3. We have defined a minimal cosegregating region containing the AD3 gene, and isolated at least 19 different transcripts encoded within this region. One of these transcripts (S182) corresponds to a novel gene whose product is predicted to contain multiple transmembrane domains and resembles an integral membrane protein. Five different missense mutations have been found that cosegregate with early-onset familial Alzheimer's disease. Because these changes occurred in conserved domains of this gene, and are not present in normal controls, they are likely to be causative of AD3.

Integrity signals

Registry

Crossref · 10.1038/375754a0

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,927
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Self-citation
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Self-citation
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Self-citation
The 1993–94 Généthon human genetic linkage map
Gyapay, G., Morissette, J., Alain Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. G., & Weissenbach, J. (1994) · Nature Genetics · doi:10.1038/ng0694supp-246 · Cited by 1,835
Structural features in eukaryotic mRNAs that modulate the initiation of translation.
Kozak, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54860-2 · Cited by 1,826
A second-generation linkage map of the human genome
Weissenbach, J., Gyapay, G., Dib, C., Alain Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G., & Lathrop, M. G. (1992) · Nature · doi:10.1038/359794a0 · Cited by 1,672

Show all 48 references

Research works printed but not linked: 8

Foncin, J.-F. et al. Rev. Neurol. 141, 194–202 (1985).
Bergamini, L. et al. Acta neurol. 13, 534–538 (1991).
Cruts, M. et al. Neurobiol Aging 15, S129 (1994).
Saleeba, J. A. & Cotton, R. G. Meth. Enzym. 217, 285–295 (1993).
Liu, Q. & Sommer, S. S. BioTechniques 18, 470–476 (1995).
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. molec. Biol. 215, 403–410 (1990). · DOI · Paper page
Schellenberg, G. D. et al. Am. J. hum. Genet. 53, 619–628 (1993).
Kosik, K. & Greenberg, S. M. in Alzheimer Disease (eds Terry, R. D., Katzman, R. & Bick, K. L.) 335–344 (Raven, New York, 1994).

Sorted by citations

Items 901–1,000 of 1,049

Murine models of brain aging and age-related neurodegenerative diseases
Jucker, M., & Ingram, D. K. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)02243-7 · Cited by 93
Biomarkers in Neurodegenerative Diseases
Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92
Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.
Arbor, S., LaFontaine, M., & Cumbay, M. G. (2016) · Europe PMC (PubMed Central) · Cited by 94
The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
Thal, D. R., & Tomé, S. O. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.006 · Cited by 92
Alzheimer’s disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production
Dimitrov, M. I., Alattia, J., Lemmin, T., Lehal, R., Fligier, A., Houacine, J., Hussain, I., Radtke, F., Peraro, M. D., Beher, D., et al. (2013) · Nature Communications · doi:10.1038/ncomms3246 · Cited by 92
Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of α-, β- and γ-secretase expression
Quiroz‐Baez, R., Rojas, E., & Arias, C. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.06.012 · Cited by 93
A mutant PSEN1 causes dementia with lewy bodies and variant Alzheimer's disease
Ishikawa, A., Piao, Y., Miyashita, A., Kuwano, R., Onodera, O., Ohtake, H., Suzuki, M., Nishizawa, M., & Takahashi, H. (2005) · Annals of Neurology · doi:10.1002/ana.20393 · Cited by 93
AßT Amyloidogenesis: Unique, or Variation on a Systemic Theme
Kisilevsky, R., Fraser, P. E., & Benson, M. D. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082674 · Cited by 92
Self-citation
Clinical, Pathological, and Biochemical Spectrum of Alzheimer Disease Associated With PS-1 Mutations
Lleó, A., Berezovska, O., Growdon, J. H., & Hyman, B. T. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200403000-00006 · Cited by 94
Intramembrane-cleaving aspartic proteases and disease: presenilins, signal peptide peptidase and their homologs
Martoglio, B., & Golde, T. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg303 · Cited by 92
Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans
Levitan, D. J., & Greenwald, I. (1998) · Development · doi:10.1242/dev.125.18.3599 · Cited by 92
The Evolution of Genetics: Alzheimer’s and Parkinson’s Diseases
Singleton, A., & Hardy, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.040 · Cited by 94
Genetic susceptibility factors for Alzheimer's disease
Richard, F., & Amouyel, P. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00903-1 · Cited by 92
Yeast as a model for studying human neurodegenerative disorders
Miller‐Fleming, L., Giorgini, F., & Outeiro, T. F. (2008) · Biotechnology Journal · doi:10.1002/biot.200700217 · Cited by 97
Withanolide A and Asiatic Acid Modulate Multiple Targets Associated with Amyloid-β Precursor Protein Processing and Amyloid-β Protein Clearance
Patil, S. P., Maki, S., Khedkar, S. A., Rigby, A. C., & Chan, C. (2010) · Journal of Natural Products · doi:10.1021/np900633j · Cited by 92
Familial Alzheimer disease: Decreases in CSF Aβ 42 levels precede cognitive decline
Moonis, M., Swearer, J. M., Dayaw, M. P. E., George‐Hyslop, P. S., Rogaeva, E. A., Kawarai, T., & Pollen, D. A. (2005) · Neurology · doi:10.1212/01.wnl.0000171397.32851.bc · Cited by 95
Self-citation
Biological function of Presenilin and its role in AD pathogenesis
Zhang, S., Zhang, M., Cai, F., & Song, W. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-15 · Cited by 97
Membrane Topology of γ-Secretase Component PEN-2
Crystal, A., Morais, V. A., Pierson, T. C., Pijak, D. S., Carlin, D., Lee, V. M. ‐., & Doms, R. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213107200 · Cited by 98
Wide range in age of onset for chromosome 1‐related familial Alzheimer's disease
Bird, T. D., Levy‐Lahad, E., Poorkaj, P., Sharma, V., Nemens, E. J., Lahad, A., Lampe, T. H., & Schellenberg, G. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400619 · Cited by 91
The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type
Castaño, E. M., Prelli, F., Soto, C. A., Beavis, R. C., Matsubara, E., Shoji, M., & Frangione, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32185 · Cited by 91
A Second Locus for Very-Late-Onset Alzheimer Disease: A Genome Scan Reveals Linkage to 20p and Epistasis between 20p and the Amyloid Precursor Protein Region
Olson, J. M., Goddard, K. A. B., & Dudek, D. M. (2002) · The American Journal of Human Genetics · doi:10.1086/341034 · Cited by 91
The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice
Hu, L., Wong, T. P., Côté, S. L., Bell, K. F. S., & Cuello, A. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00394-4 · Cited by 90
Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic
Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 93
Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease
Crist, A. M., Hinkle, K. M., Wang, X., Moloney, C. M., Matchett, B. J., Labuzan, S. A., Frankenhauser, I., Azu, N. O., Liesinger, A. M., Lesser, E. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22399-3 · Cited by 93
Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and Aβ Secretion
Hiltunen, M. O., Lu, A., Thomas, A. V., Romano, D., Kim, M., Jones, P., Xie, Z., Kounnas, M. Z., Wagner, S. L., Berezovska, O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603106200 · Cited by 92
Self-citation
An Overview of Genome-Wide Association Studies in Alzheimer’s Disease
Shen, L., & Jia, J. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0011-3 · Cited by 93
Association of the mitochondrial tRNAA4336G mutation with Alzheimer's and Parkinson's diseases
Egensperger, R., Kösel, S., Schnopp, N. M., Mehraein, P., & Graeber, M. B. (1997) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1997.tb01301.x · Cited by 90
Neuronal Localization of Presenilin-1 and Association with Amyloid Plaques and Neurofibrillary Tangles in Alzheimer’s Disease
Busciglio, J. A., Hartmann, H., Lorenzo, A., Wong, C. W., Baumann, K., Sommer, B., Staufenbiel, M., & Yankner, B. A. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05101.1997 · Cited by 91
Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains
Elder, G. A., Tezapsidis, N., Carter, J. E., Shioi, J., Bouras, C., Li, H. ‐., Johnston, J. M., Efthimiopoulos, S., Friedrich, V. L., & Robakis, N. K. R. K. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960801)45:3 · Cited by 91
β-Amyloid Prions and the Pathobiology of Alzheimer’s DiseasePreprint
Watts, J. C., & Prusiner, S. B. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a023507 · Cited by 90
Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases
Knuesel, I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.002 · Cited by 89
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
Pritchard, S. M., Dolan, P. J., Vitkus, A., & Johnson, G. V. W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01273.x · Cited by 89
Homophilic Interactions of the Amyloid Precursor Protein (APP) Ectodomain Are Regulated by the Loop Region and Affect β-Secretase Cleavage of APP
Kaden, D., Munter, L. M., Joshi, M., Treiber, C., Weise, C., Bethge, T., Voigt, P., Schaefer, M., Beyermann, M., Reif, B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708046200 · Cited by 89
Akt/GSK3β serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations
Ryder, J. W., Yuan, S., & Ni, B. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.07.004 · Cited by 92
Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China
Guo, T.-W., Zhang, F.-C., Yang, M.-S., Gao, X.-C., Bian, L., Duan, S.-W., Zheng, Z.-J., Gao, J.-J., Wang, H., Li, R.-L., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019190 · Cited by 89
Molecular basis of Alzheimer's disease
Drouet, B., Pinçon‐Raymond, M., Chambaz, J., & Pillot, T. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050035 · Cited by 96
β‐Amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury
Horsburgh, K. J., Cole, G. M., Yang, F., Savage, M. J., Greenberg, B., Gentleman, S. M., Graham, D. I., & Nicoll, J. A. R. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.026002124.x · Cited by 88
Environmental Pesticide Exposure as a Risk Factor for Alzheimer's Disease: A Case-Control Study
Gauthier, E., Fortier, I., Courchesne, F., Pepin, P., Mortimer, J. A., & Gauvreau, D. (2001) · Environmental Research · doi:10.1006/enrs.2001.4254 · Cited by 92
Nerve Growth Factor and Alzheimer's Disease: New Facts for an Old Hypothesis
Cattaneo, A., & Calissano, P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8310-9 · Cited by 93
Restored degradation of the Alzheimer’s amyloid‐β peptide by targeting amyloid formation
Crouch, P. J., Tew, D. J., Du, T., Nguyen, D., Caragounis, A., Filiz, G., Blake, R. E., Trounce, I. A., Soon, C. P. W., Laughton, K. M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05870.x · Cited by 88
Role of Mitochondria-Associated Endoplasmic Reticulum Membrane in Inflammation-Mediated Metabolic Diseases
Thoudam, T., Jeon, J., Ha, C., & Lee, I. (2016) · Mediators of Inflammation · doi:10.1155/2016/1851420 · Cited by 91
Multipoint Oligogenic Analysis of Age-at-Onset Data with Applications to Alzheimer Disease Pedigrees
Daw, E. W., Heath, S. C., & Wijsman, E. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302276 · Cited by 88
The genetics of late-onset Alzheimerʼs disease
Myers, A., & Goate, A. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00002 · Cited by 88
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects
Villain, N., Planche, V., & Levy, R. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.06.012 · Cited by 87
Synaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms
Forero, D. A., Casadesús, G., Perry, G. L., & Arboleda, H. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00439.x · Cited by 89
Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators
Checler, F., & Vincent, B. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02263-4 · Cited by 89
p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction
Kesavapany, S., Lau, K., McLoughlin, D. M., Brownlees, J., Ackerley, S., Leigh, P. N., Shaw, C. E., & Miller, C. C. J. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01376.x · Cited by 87
β-Secretase Processing of the Alzheimer's Amyloid Protein Precursor (APP)
Marlow, L. A., Cain, M., Pappolla, M. A., & Sambamurti, K. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:233 · Cited by 87
Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease
Lambert, J.-C., Ramirez, A., Grenier-Boley, B., & Bellenguez, C. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02076-1 · Cited by 87
Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population
Chen, L. H., Kao, P. Y. P., Fan, Y., Ho, D. T. Y., Chan, C. S. Y., Yik, P. Y., Ha, J. C. T., Chu, L., & Song, Y. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.016 · Cited by 89
Aluminum and Amyloid-β in Familial Alzheimer’s Disease
Mold, M. J., Linhart, C., Gómez‐Ramirez, J., Villegas‐Lanau, A., & Exley, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191140 · Cited by 86
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice
Ordóñez‐Gutiérrez, L., Re, F., Bereczki, E., Ioja, E., Gregori, M., Andersen, A. J., Antón, M., Moghimi, S. M., Pei, J.-J., Masserini, M., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.015 · Cited by 86
Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility
Theuns, J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.16.2383 · Cited by 89
Mitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86
Mutant Presenilin 2 Transgenic Mice
Sawamura, N., Morishima‐Kawashima, M., Waki, H., Kobayashi, K., Kuramochi, T., Frosch, M. P., Ding, K., Ito, M., Kim, T., Tanzi, R. E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004308200 · Cited by 89
Self-citation
Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity
Cotter, R. L., Burke, W. J., Thomas, V. S., POTTER, J. F., Zheng, J., & Gendelman, H. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.416 · Cited by 86
Free radical theory of aging: Alzheimer’s disease pathogenesis
Harman, D. (1995) · AGE · doi:10.1007/bf02436085 · Cited by 87
Genetic factors in Alzheimer's disease: A review of recent advances
Levy‐Lahad, E., & Bird, T. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400604 · Cited by 86
Sorting Nexin 27 Regulates Aβ Production through Modulating γ-Secretase Activity
Wang, X., Huang, T., Zhao, Y., Zheng, Q., Thompson, R. C., Bu, G., Zhang, Y.-W., Hong, W., & Xu, H. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.037 · Cited by 77
An overview of the genes and biomarkers in Alzheimer’s disease
Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Wang, T., Bei, K., Changalath, C., & Rajasekaran, J. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102599 · Cited by 89
Transgenic C. elegans as a Model in Alzheimers Research
Wu, Y., & Luo, Y. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772768 · Cited by 88
Towards a complete resolution of the genetic architecture of disease
Singleton, A., Hardy, J., Traynor, B. J., & Houlden, H. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.07.004 · Cited by 85
Novel mutations and repeated findings of mutations in familial Alzheimer disease
Finckh, U., Kuschel, C., Anagnostouli, M. C., Patsouris, E., Pantes, G. V., Gatzonis, S. D., Kapaki, E. N., Davaki, P., Lamszus, K., Stavrou, D., et al. (2005) · Neurogenetics · doi:10.1007/s10048-005-0211-x · Cited by 87
A review of genome mutation and Alzheimer's disease
Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 88
Variant Alzheimer Disease With Spastic paraparesis: Neuropathological phenotype
Verkkoniemi, A., Kalimo, H., Paetau, A. E., Somer, M., Iwatsubo, T., Hardy, J., & Haltia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.5.483 · Cited by 85
Separation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch
Kulic, L., Walter, J., Multhaup, G., Teplow, D. B., Baumeister, R., Romig, H., Capell, A., Steiner, H., & Haass, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100049897 · Cited by 85
Aβ1–40 but not Aβ1–42 levels in cortex correlate with apolipoprotein E ϵ4 allele dosage in sporadic Alzheimer's disease
Ishii, K., Tamaoka, A., Mizusawa, H., Shoji, S.-I., Ohtake, T., Fraser, P. E., Takahashi, H., Tsuji, S., Gearing, M., Mizutani, T., et al. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01363-7 · Cited by 85
Self-citation
Shifting paradigms: The central role of microglia in Alzheimer’s disease
Schwabe, T., Srinivasan, K., & Rhinn, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104962 · Cited by 84
Stem Cell Therapies for Neurodegenerative Diseases
Sugaya, K., & Vaidya, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-74470-4_5 · Cited by 84
The oxidative hypothesis of senescence
Gîlcă, M., Stoian, I. A.-M., Atanasiu, V., & Vîrgolici, B. (2007) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.33869 · Cited by 85
Endogenous Presenilin-1 Targets to Endocytic Rather Than Biosynthetic Compartments
Lah, J. J., & Levey, A. I. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0861 · Cited by 84
Pharmacological Knock-down of the Presenilin 1 Heterodimer by a Novel γ-Secretase Inhibitor
Beher, D., Wrigley, J. D. J., Nadin, A. J., Evin, G. M., Masters, C. L., Harrison, T., Castro, J. L., & Shearman, M. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103075200 · Cited by 84
A 1.1-Mb Transcript Map of the Hereditary Hemochromatosis LocusPreprint
Ruddy, D. A., Kronmal, G. S., Lee, V., Mintier, G. A., Quintana, L., Domingo, R., Meyer, N. C., Irrinki, A., McClelland, E. E., Fullan, A., et al. (1997) · Genome Research · doi:10.1101/gr.7.5.441 · Cited by 85
Presenilin-1 Mutations in Alzheimer's Disease: An Update on Genotype-Phenotype Relationships
Larner, A. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130746 · Cited by 86
Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part I: Target Disorders and Concept Approaches to Gene Therapy of the Central Nervous System
Zloković, B. V., & Apuzzo, M. L. J. (1997) · Neurosurgery · doi:10.1097/00006123-199704000-00027 · Cited by 83
The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk
Fan, J., Tao, W., Li, X., Li, H., Zhang, J., Wei, D., Chen, Y., & Zhang, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051177 · Cited by 87
Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
He, H., Dong, W., & Huang, F. P. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246137 · Cited by 83
γ-Secretase as a Target for Alzheimer’s Disease
Wolfe, M. S. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00004-0 · Cited by 85
NEDD8 protein is involved in ubiquitinated inclusion bodies
Kuazi, A. D., Kito, K., Abe, Y., Shin, R., Kamitani, T., & Ueda, N. (2003) · The Journal of Pathology · doi:10.1002/path.1283 · Cited by 83
γ-Secretase Catalyzes Sequential Cleavages of the AβPP Transmembrane Domain
Xu, X. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0957 · Cited by 84
Initial results of a genome survey for novel alzheimer's disease risk genes: association with a locus on the X chromosome
Zubenko, G. S., Stiffler, J. S., Hughes, H. B., Hurtt, M. R., & Kaplan, B. B. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980207)81:1 · Cited by 29
Self-citation
β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease
Andreasen, N., & Blennow, K. (2002) · Peptides · doi:10.1016/s0196-9781(02)00056-6 · Cited by 86
Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease
Iivonen, S., Corder, E. H., Lehtovirta, M., Helisalmi, S., Mannermaa, A., Vepsäläinen, S., Hänninen, T., Soininen, H. S., & Hiltunen, M. O. (2004) · Neurology · doi:10.1212/01.wnl.0000118208.16939.60 · Cited by 83
Drosophila presenilinIs Required for Neuronal Differentiation and Affects Notch Subcellular Localization and Signaling
Guo, Y., Livne‐Bar, I., Zhou, L., & Boulianne, G. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08435.1999 · Cited by 84
GSK3β overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus
Sirerol‐Piquer, M., Gómez‐Ramos, P., Hernández, F., Pérez, M., Morán, M. A., Fuster-Matanzo, A., Lucas, J. J., Ávila, J., & García‐Verdugo, J. M. (2010) · Hippocampus · doi:10.1002/hipo.20805 · Cited by 83
Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?
Su, B., Wang, X., Bonda, D., Perry, G. L., Smith, M. A., & Zhu, X. (2010) · Molecular Neurobiology · doi:10.1007/s12035-009-8095-7 · Cited by 85
Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease
Jones, L., Harold, D. H., & Williams, J. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.005 · Cited by 82
Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease
Hamaguchi, T., Ono, K., & Yamada, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5599-9 · Cited by 83
Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer's disease
Prasad, K. N. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.01.002 · Cited by 83
Protein Phosphorylation is a Key Mechanism in Alzheimer’s Disease
Oliveira, J. M., Costa, M. G. C., Cachide, M., Silva, O. A. B. D. C. E., & Henriques, A. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170176 · Cited by 84
Intramembrane proteolysis by presenilin and presenilin-like proteases
Xia, W., & Wolfe, M. S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00651 · Cited by 83
Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys
Nakamura, S., Nakayama, H., Naoaki, G. O. T. O., Ono, F., Sakakibara, I., & Yoshikawa, Y. (1998) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.1998.tb00244.x · Cited by 84
Reverse genetic analysis of Caenorhabditis elegans presenilins reveals redundant but unequal roles for sel- 12 and hop- 1 in Notch-pathway signaling
Westlund, B., Parry, D., Clover, R., Basson, M., & Johnson, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2497 · Cited by 82
Protein misfolding in the late‐onset neurodegenerative diseases: Common themes and the unique case of amyotrophic lateral sclerosis
Mulligan, V. K., & Chakrabartty, A. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24285 · Cited by 81
Proteomics in animal models of Alzheimer's and Parkinson's diseases
Robinson, R. A. S., Owen, J. B., & Butterfield, D. A. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.003 · Cited by 81
The Relationship between Amyloid and Tau
Hardy, J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:203 · Cited by 80
The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases
Walter, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.704981 · Cited by 80
Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases.
Kawahara, M., Kato-Negishi, M., & Tanaka, K. (2017) · Metallomics · doi:10.1039/c7mt00046d · Cited by 80
APOE and other loci affect age‐at‐onset in Alzheimer's disease families with PS2 mutation
Wijsman, E. M., Daw, E. W., Yu, X., Steinbart, E. J., Nochlin, D., Bird, T. D., & Schellenberg, G. D. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30087 · Cited by 79
Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
Szyf, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.009 · Cited by 76

Authors: Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., & St George-Hyslop, P. H.
Affiliations: University of Toronto (CA)
Inserm (FR)
University of Florence (IT)
University of Turin (IT)
National Institutes of Health (US)
Fondation Jean Dausset-CEPH (FR)
University of Massachusetts Chan Medical School (US)
Western General Hospital (GB)
Sandoz Group AG (Switzerland) (CH)
Harvard University (US)
Duke University (US)
ORCID: Rogaev, E. I.
Liang, Y.
Rogaeva, E. A.
Ikeda, M.
Lin, C.
Tsuda, T.
Bruni, A. C.
Sorbi, S.
Rainero, I.
Pinessi, L.
Brookes, A.
Haines, J. L.
Tanzi, R. E.
Rommens, J. M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1995-06
Volume: 375
Issue: 6534
Pages: 754-760
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/375754a0
OpenAlex: W2046209489
Cited by: 4,051
References: 48
Citations by year: 2026: 36 · 2025: 70 · 2024: 78 · 2023: 54 · 2022: 93 · 2021: 93 · 2020: 118 · 2019: 107 · 2018: 105 · 2017: 116 · 2016: 140 · 2015: 100 · 2014: 132 · 2013: 120 · 2012: 134
FWCI: 144.01
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Florence Research (University of Florence) (submittedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders: Canadian Institutes of Health Research (64309)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: early-onset familial Alzheimer's disease, missense mutations, autosomal dominant inheritance, gene cloning, co-segregation, transmembrane proteins, novel genes, susceptibility genes
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Animals, Base Sequence, Chromosome Mapping, Chromosomes, Human, Pair 14, Cloning, Molecular, Female, Humans, Male, Membrane Proteins, Molecular Sequence Data, Mutation, Pedigree, Transcription, Genetic, Open Reading Frames, Protein Structure, Secondary, Mice, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks